Bosh sahifa007570 ā¢ KRX
add
Ilyang Pharmaceutical Co Ltd
Yopilish kursi
13Ā 050,00Ā ā©
Yillik diapazon
9Ā 540,00Ā ā© - 15Ā 490,00Ā ā©
Bozor kapitalizatsiyasi
254,79Ā mlrd KRW
Narx/foyda
14,95
Dividend daromadliligi
1,15%
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (KRW) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 68,83Ā mlrd | -0,38% |
Joriy xarajat | 27,66Ā mlrd | 9,71% |
Sof foyda | 8,44Ā mlrd | 141,68% |
Sof foyda marjasi | 12,26 | 142,77% |
Har bir ulushga tushum | ā | ā |
EBITDA | 1,93Ā mlrd | -71,68% |
Amaldagi soliq stavkasi | 26,58% | ā |
Balans
Jami aktivlari
Jami passivlari
| (KRW) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 16,47Ā mlrd | -38,71% |
Jami aktivlari | 452,76Ā mlrd | -15,15% |
Jami passivlari | 204,95Ā mlrd | -21,85% |
Umumiy kapital | 247,81Ā mlrd | ā |
Tarqatilgan aksiyalar | 18,42Ā mln | ā |
Narxi/balansdagi bahosi | 0,99 | ā |
Aktivlardan daromad | -0,09% | ā |
Kapitaldan daromad | -0,11% | ā |
Pul aylanmasi
Naqd pulning sof oŹ»zgarishi
| (KRW) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 8,44Ā mlrd | 141,68% |
Operatsiyalardan naqd pul | 6,80Ā mlrd | 197,54% |
Sarmoyadan naqd pul | 284,16Ā mln | 102,01% |
Moliyadan naqd pul | -3,22Ā mlrd | -115,04% |
Naqd pulning sof oŹ»zgarishi | 4,12Ā mlrd | 43Ā 277,18% |
BoŹ»sh pul | -7,60Ā mlrd | 67,58% |
Haqida
Tashkil etilgan
1-iyl, 1946
Xodimlar soni
670
